| [1] |
Mary Ann A DeMichele-Sweet Ph D，Robert A.Genetics of psychosis in Alzheimer disease[J].Curr Genet Med Rep，2014，2（1）：30-38.
|
| [2] |
Cervellati C，Wood PL，Romani A，et al.Oxidative challenge in Alzheimer′s disease：state of knowledge and future needs[J]. Amer Fed Clin Res，2016，64（1）：21-32.
|
| [3] |
Simic G，Babic Leko M，Wray S，et al.Tau Protein Hyperphosphorylation and Aggregation in Alzheimer′s Disease and Other Tauopathies，and Possible Neuroprotective Strategies[J]. Biomolecules，2016，6（6）：1-28.
|
| [4] |
Ricciarelli R，Canepa E，Marengo B，et al.Cholesterol and Alzheimer′s disease：a still poorly understood correlation[J]. IUBMB life，2012，12（64）：931-935.
|
| [19] |
DeKosky ST.Statin therapy in the treatment of Alzheimer disease：what is the rationale?[J].Am J Med，2005，12（12）：48-53.
|
| [5] |
DiasHK，BrownCL，PolidoriMC，etal.LDL-lipidsfrompatients with hypercholesterolaemia and Alzheimer′s disease are inflammatory to microvascular endothelial cells：mitigation by statin intervention[J].Clin Sci，2015，129（12）：1195-1206.
|
| [6] |
Kuo PH，Lin CI，Chen YH，et al.A high-cholesterol diet enriched with polyphenols from Oriental plums（Prunus salicina）improves cognitive function and lowers brain cholesterol levels and neurodegenerative-related protein expression in mice[J].Brit J Nutr，2015，113（10）：1550-1557.
|
| [7] |
Mamada N，Tanokashira D，Hosaka A，et al.Amyloid betaprotein oligomers upregulate the beta-secretase，BACE1，through a post-translational mechanism involving its altered subcellular distribution in neurons[J].Mol Brain，2015，11（8）：73-77.
|
| [8] |
Shimizu H，Tosaki A，Kaneko K，et al.Crystal structure of an active form of BACE1，an enzyme responsible for amyloid beta protein production[J].Mol Cell Biol，2008，28（11）：3663-3671.
|
| [9] |
Devi L，Ohno M.Effects of BACE1 haploinsufficiency on APP processing and Abeta concentrations in male and female 5XFAD Alzheimer mice at different disease stages[J]. Neuroscience，2015，307（8）：128-137.
|
| [10] |
Ohno-Matsui K.Parallel findings in age-related macular degeneration and Alzheimer′s disease[J].Prog Retin Eye Res，2011，30（4）：217.
|
| [11] |
Parsons CG，Ruitenberg M，Freitag CE，et al.Rammes G. MRZ-99030-A novel modulator of Abeta aggregation：IMechanism of action（MoA）underlying the potential neuroprotective treatment of Alzheimer′s disease，glaucoma and age-related macular degeneration（AMD）[J].Neuropharmacol，2015，92（21）：158-169.
|
| [12] |
Iaccarino HF，Singer AC，Martorell AJ，et al.Gamma frequency entrainment attenuates amyloid load and modifies microgli[J].Nature，2016，540（32）：230-235.
|
| [13] |
Ourdev D，Foroutanpay BV，Wang Y，et al.The Effect of Aβ1-42Oligomers on APP Processing and Aβ1-40Generation in Cultured U-373 Astrocytes[J].Neuro-degenerat Dis，2015，15（6）：361-368.
|
| [14] |
Dobrowolska JA，Michener MS，Wu G，et al.CNS amyloidbeta，soluble APP-alpha and-beta kinetics during BACE inhibition[J].Neurosci，2014，34（24）：8336-8346.
|
| [15] |
Tang Y，Peng Y，Liu J，et al.Early inflammation-associated factors blunt sterol regulatory element-binding proteins-1-mediated lipogenesis in high-fat diet-fed APP/PSEN1dE9 mouse model of Alzheimer′s diseas[J].J Neurochem，2015，136（4）：791-803.
|
| [16] |
Cui W，Sun Y，Wang Z，et al.Activation of liver X receptor decreases BACE1 expression and activity by reducing membrane cholesterol levels[J].Neurochem Res，2011，36（10）：1910-1921.
|
| [17] |
Savage MJ，Holder DJ，Wu G，et al.Soluble BACE-1 activity and sAβPPβ concentrations in Alzheimer′s disease and age-matched healthy control cerebrospinal fluid from the Alzheimer′s disease neuroimaging initiative-1 baseline cohort[J].JAD，2015，46（2）：431-440.
|
| [18] |
Stromberg K，Eketjall S，Georgievska B，et al.Combining an amyloid-beta（Abeta）cleavingenzymeinhibitorwithagamma-secretasemodulatorresultsinanadditivereductionofA-beta production[J].FEBS J，2015，282（1）：65-73.
|
| [20] |
Li G，Larson EB，Sonnen JA，et al.Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease[J].Neurology，2008，69（9）：878-885.
|
京公网安备 11010502046607号